Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen.
Yang MH, Chen TH, Wang HM, Hsieh JC, Huang HC, Hsieh MC, Yen CJ, Wu SY, Hua CH, Lien MY, Chang YF, Wang HC, Chien CY, Huang TL, Lu HJ, Lin JC, Wang CC, Liu YC, Chen JP, Lu WC, Yiu CY, Lin CL, Lou PJ, Chu PY.
Yang MH, et al. Among authors: lu wc.
BMC Cancer. 2024 Oct 5;24(1):1227. doi: 10.1186/s12885-024-12425-0.
BMC Cancer. 2024.
PMID: 39369189
Free PMC article.